Suppr超能文献

[老年人心律失常治疗的风险]

[Risks of the anti-arrhythmia treatment in the elderly].

作者信息

Nigond J, Bertinchant J P

机构信息

Service de Cardiologie, CHRU de Nîmes.

出版信息

Ann Cardiol Angeiol (Paris). 1990 Nov;39(9):535-9.

PMID:2291620
Abstract

The amount of drugs taken by elderly patients over 70 years old increases with the increase of the average age in western countries; this drug consumption, statistically higher than that of the whole population, concerns mainly cardio-vascular drugs; anti-arrhythmics occupy a large place, the therapeutic indications differing only slightly from those of the young subject. The report on the observations enables us to draw the attention on the increasing predisposition, in these age groups, to side effects which are often serious, calling into question the vital prognosis. Modifications in the pharmacokinetics and the pharmacodynamics, associated with a frequent polymedication and a risk of error in the drug absorption are factors to be taken into account when prescribing anti-arrhythmic drugs to elderly patients.

摘要

在西方国家,70岁以上老年患者的用药量随着平均年龄的增长而增加;这种药物消费量在统计学上高于全体人口,主要涉及心血管药物;抗心律失常药物占很大比例,其治疗适应症与年轻患者的治疗适应症仅有轻微差异。观察报告使我们能够关注到,在这些年龄组中,出现严重副作用的易感性日益增加,这对生命预后提出了质疑。在给老年患者开抗心律失常药物时,需要考虑到药代动力学和药效学的改变,以及频繁的联合用药和药物吸收错误的风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验